fasudil has been researched along with Pain in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this article, the potential analgesic effects of Fasudil in a range of preclinical pain models were assessed." | 7.76 | Characterization of Fasudil in preclinical models of pain. ( Boyce-Rustay, JM; Chu, KL; Honore, P; McGaraughty, S; Simler, GH; Vasudevan, A; Wensink, EJ, 2010) |
| "In this article, the potential analgesic effects of Fasudil in a range of preclinical pain models were assessed." | 3.76 | Characterization of Fasudil in preclinical models of pain. ( Boyce-Rustay, JM; Chu, KL; Honore, P; McGaraughty, S; Simler, GH; Vasudevan, A; Wensink, EJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyce-Rustay, JM | 1 |
| Simler, GH | 1 |
| McGaraughty, S | 1 |
| Chu, KL | 1 |
| Wensink, EJ | 1 |
| Vasudevan, A | 1 |
| Honore, P | 1 |
1 other study available for fasudil and Pain
| Article | Year |
|---|---|
Characterization of Fasudil in preclinical models of pain.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Analgesics; Animals; Disease Models, Animal; Male; Pa | 2010 |